HERAMED LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0175 AUD | -12.50% |
|
0.00% | -27.08% |
| Mar. 13 | HeraMED Partners With FemBridge for Maternity Health Service; Shares Jump 15% | MT |
| Mar. 11 | Heramed Limited Announces Board Changes | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 9.876 | 11.58 | 12.7 | 32.8 | 20.67 | 5.251 |
| Enterprise Value (EV) 1 | 5.993 | 9.744 | 10.95 | 32.63 | 18.2 | 4.676 |
| P/E ratio | -1.11 x | -3.18 x | -3.17 x | -5.33 x | -3.74 x | -0.95 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 128 x | 79.7 x | 321 x | 378 x | 94.4 x | 13 x |
| EV / Revenue | 77.7 x | 67 x | 277 x | 377 x | 83.2 x | 11.6 x |
| EV / EBITDA | -2.09 x | -3.02 x | -3.18 x | -8.3 x | -5.75 x | -1.07 x |
| EV / FCF | -8.52 x | -5.31 x | -6.34 x | -11.9 x | -6.07 x | -2.1 x |
| FCF Yield | -11.7% | -18.8% | -15.8% | -8.41% | -16.5% | -47.7% |
| Price to Book | 2.28 x | 4.85 x | 6.36 x | -309 x | 7.22 x | 11.3 x |
| Nbr of stocks (in thousands) | 87,529 | 103,213 | 150,039 | 188,230 | 242,657 | 321,264 |
| Reference price 2 | 0.1128 | 0.1122 | 0.0846 | 0.1742 | 0.0852 | 0.0163 |
| Announcement Date | 3/29/19 | 3/27/20 | 3/29/21 | 3/29/22 | 3/22/23 | 3/28/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.0772 | 0.1454 | 0.0395 | 0.0867 | 0.2189 | 0.4029 |
| EBITDA 1 | -2.868 | -3.224 | -3.446 | -3.933 | -3.165 | -4.381 |
| EBIT 1 | -2.875 | -3.229 | -3.451 | -3.939 | -3.181 | -4.432 |
| Operating Margin | -3,725.46% | -2,221.15% | -8,733.2% | -4,545.68% | -1,453.02% | -1,100.13% |
| Earnings before Tax (EBT) 1 | -3.766 | -3.129 | -3.359 | -5.709 | -4.881 | -4.503 |
| Net income 1 | -3.766 | -3.129 | -3.359 | -5.709 | -4.881 | -4.503 |
| Net margin | -4,880.82% | -2,152.08% | -8,500.28% | -6,588.2% | -2,229.48% | -1,117.6% |
| EPS 2 | -0.1019 | -0.0353 | -0.0267 | -0.0327 | -0.0228 | -0.0173 |
| Free Cash Flow 1 | -0.7036 | -1.834 | -1.726 | -2.743 | -2.999 | -2.231 |
| FCF margin | -911.83% | -1,261.7% | -4,367.39% | -3,165.12% | -1,369.93% | -553.79% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/29/19 | 3/27/20 | 3/29/21 | 3/29/22 | 3/22/23 | 3/28/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 3.88 | 1.84 | 1.75 | 0.17 | 2.46 | 0.57 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -0.7 | -1.83 | -1.73 | -2.74 | -3 | -2.23 |
| ROE (net income / shareholders' equity) | -166% | -93% | -153% | -603% | -354% | -271% |
| ROA (Net income/ Total Assets) | -52.9% | -44.2% | -63.5% | -63.3% | -45.5% | -89.8% |
| Assets 1 | 7.119 | 7.076 | 5.293 | 9.024 | 10.74 | 5.015 |
| Book Value Per Share 2 | 0.0500 | 0.0200 | 0.0100 | -0 | 0.0100 | 0 |
| Cash Flow per Share 2 | 0.0500 | 0.0200 | 0.0100 | 0.0200 | 0.0100 | 0 |
| Capex 1 | 0.01 | 0.01 | 0 | 0.02 | 0 | 0 |
| Capex / Sales | 6.55% | 4.45% | 11.84% | 21.65% | 2.12% | 0.35% |
| Announcement Date | 3/29/19 | 3/27/20 | 3/29/21 | 3/29/22 | 3/22/23 | 3/28/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -27.08% | 4.03M | |
| +4.55% | 3.48B | |
| -12.80% | 156M | |
| -15.69% | 81.85M | |
| +30.43% | 59.71M |
- Stock Market
- Equities
- HMD Stock
- Financials HeraMED Limited
